Potent Inhibitors of HIV-1 Integrase Display a Two-Step, Slow-Binding Inhibition Mechanism Which Is Absent in a Drug-Resistant T66I/M154I Mutant

التفاصيل البيبلوغرافية
العنوان: Potent Inhibitors of HIV-1 Integrase Display a Two-Step, Slow-Binding Inhibition Mechanism Which Is Absent in a Drug-Resistant T66I/M154I Mutant
المؤلفون: Halsey W, Carter Hl rd, Edward P. Garvey, Weaver Kl, Sathe G, Lang S, Schwartz B, Gartland Mj
المصدر: Biochemistry. 48:1644-1653
بيانات النشر: American Chemical Society (ACS), 2009.
سنة النشر: 2009
مصطلحات موضوعية: Base Sequence, biology, Elvitegravir, Chemistry, Mutant, Kinetics, Integrase inhibitor, HIV Integrase, Pharmacology, Raltegravir, Biochemistry, In vitro, Integrase, Drug Resistance, Viral, Mutation, HIV-1, medicine, biology.protein, Potency, HIV Integrase Inhibitors, DNA Primers, medicine.drug
الوصف: Two-metal binding HIV-1 integrase inhibitors (INIs) are potent inhibitors of HIV-1 in vitro and in patients. We report here for the first time the kinetics of inhibition of integrase-catalyzed strand transfer. First, the IC(50) values for each of six structurally distinct INIs decreased when a preincubation was included: S-1360 (1.3 microM vs 0.12 microM), L-731,988 (130 nM vs 9 nM), L-870,810 (130 nM vs 4 nM), raltegravir (300 nM vs 9 nM), elvitegravir (90 nM vs 6 nM), and GSK364735 (90 nM vs 6 nM). When reactions with these INIs were initiated with integrase, progress curve analyses indicated time-dependent inhibition, which could be fitted to a two-step mechanism of binding. Overall fitted K(i) values matched the IC(50) values measured with a preincubation: S-1360 (0.17 microM), L-731,988 (34 nM), L-870,810 (2.4 nM), raltegravir (10 nM), elvitegravir (4.0 nM), and GSK364735 (2.5 nM). To begin to understand the mechanism for this slow onset of inhibition and its possible impact on drug resistance, studies of resistance mutations were initiated. T66I/M154I exhibited little if any time-dependent inhibition by any of the six INIs, as measured by differences in potency upon preincubation or by progress curve analysis. These data demonstrate that slow binding is a signature of two-metal binding INIs, and that the second slow step is required for full potency. We discuss a possible structural explanation of the second slow step of inhibition and also the relationship between loss of time-dependent inhibition and drug resistance of this important new class of HIV-1 antiretroviral drugs.
تدمد: 1520-4995
0006-2960
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23ec5f18cf425be2daeefcd6cc994aac
https://doi.org/10.1021/bi802141y
رقم الأكسشن: edsair.doi.dedup.....23ec5f18cf425be2daeefcd6cc994aac
قاعدة البيانات: OpenAIRE